Management of PN-induced cholestasis

Practical Gastroenterology

Volumn 29, Issue 2, 2005, Pages 62-68

  Jeejeebhoy, Khursheed N ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINO ACID; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOHYDRATE; CARNITINE; CHROMIUM; COMFREY EXTRACT; COPPER; EPHEDRA SINICA EXTRACT; GLUCOSE; GLYCINE; HERBACEOUS AGENT; JIN BU HUAN; LIPID; MANGANESE; METRONIDAZOLE; SELENIUM; TAUROURSODEOXYCHOLIC ACID; TRACE ELEMENT; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VALERIAN; ZINC;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALGORITHM; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL OVERGROWTH; BILIARY TRACT DISEASE; BILIRUBIN BLOOD LEVEL; CALORIC INTAKE; CARNITINE DEFICIENCY; CHOLESTASIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG TOXICITY; ENDOTOXEMIA; HUMAN; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; NUTRIENT; PARENTERAL NUTRITION; REVIEW; SEPSIS; VIRUS HEPATITIS;

EID: 14744283270     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Reimund JM, Duclos B, Arondel Y, Baumann R. Persistent inflammation and immune activation contribute to cholestasis in patients receiving home parenteral nutrition. Nutrition, 2001;17:300-304.
2. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of Liver Disease and Contributing Factors in Patients Receiving Home Parenteral Nutrition for Permanent Intestinal Failure. Ann Intern Med, 2000;132:525-532.
3. Buchmiller CE, Kleiman-Wexler RL, Ephgrave KS, Booth B, Hensley CE 2nd. Liver dysfunction and energy source: results of a randomized clinical trial. J Parenter Enteral Nutr, 1993;17:301-306.
4. Heubi JE, Wiechmann DA, Creutzinger V, Setchell KD, Squires R Jr, Couser R, Rhodes P. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr, 2002;141:237-242.
5. Stanko RT, Nathan G, Mendelow H, Adibi SA. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology, 1987; 92(1):197-202.
6. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology, 1980; 79(1):131-137.
7. Kubota A, Yonekura T, Hoki M, et al. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 year's experience. J Pediatr Surg, 2000;35:1049-1051.
8. Bolder U, Ton-Nu H-T, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology, 1997;112:214-225.
9. Moseley RH. Sepsis and Cholestasis. Clin Liver Dis, 2004;8:83-94.
10. Moseley RH. Sepsis and cholestasis. Clin Liver Dis, 1999;3:465-475.
11. O'Brien DP, Nelson LA, Kemp CJ, Williams JL, Wang Q, Erwin CR, Hasselgren PO, Warner BW. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg, 2002;37:390-394.
12. Latham PS, Menkes E, Phillips MJ, Jeejeebhoy KN. Hyperalimentation- associated jaundice: an example of a serum factor inducing cholestasis in rats. Am J Clin Nutr, 1985; 41:61-65.
13. Takehara H, Hino M, Kameoka K, Komi N. A new method of total parenteral nutrition for surgical neonates: it is possible that cyclic TPN prevents intrahepatic cholestasis. Tokushima J Exp Med, 1990;37:97-102.
14. Wolman SL, Anderson GH, Marliss EB and Jeejeebhoy KN. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology, 1979; 76: 458-467.
15. Capron JP, Gineston JL, Herve MA, Braillon A. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet, 1983;1(8322):446-447.
16. Kubota A, Okada A, Imura K, Kawahara H, Nezu R, Kamata S, Takagi Y. The effect of metronidazole on TPN-associated liver dysfunction in neonates. J Pediatr Surg, 1990; 25: 618-621.
17. Worthley LI, Fishlock RC, Snoswell AM. Carnitine deficiency with hyperbilirubinemia, generalized skeletal muscle weakness and reactive hypoglycemia in a patient on long-term total parenteral nutrition: treatment with intravenous L-carnitine. J Parenter Enterai Nutr, 1983;7:176-180.
18. Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report. Gastroenterology, 1991;101:250-253.
19. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab, 1999;12:549-553.
20. Dahms BB, Halpin TC. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. Gastroenterology, 1981; 81:136-144.